Home·Stocks·XENE

XENE

XNAS

Xenon Pharmaceuticals Inc

Basic Materials · Pharmaceutical Preparations

$54.73
-0.06 (-0.11%)
15-min delayed

Drag to pan · Scroll to zoom · Hover for OHLC

Snapshot
Loading metrics…
About Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Employees
370
Country
US
IPO Date
2014-11-05
www.xenon-pharma.com →
Recent News
JP Morgan Maintains Overweight on Xenon Pharmaceuticals, Raises Price Target to $82
Benzinga · 3d ago
COMMUNITY · $XENE0 theses
POST YOUR TAKE →
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Ask AI about XENEBuild basket with XENEScreener

Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.

XENE Xenon Pharmaceuticals Inc Stock — $54.73 -0.11% · AlgoThesis